Return to content in this issue

 

Successful Desensitization to Tezepelumab in a Polysorbate-Allergic Patient

Bautista-Villanueva S1, Mateos-Salvador M2, Arrojo Fuentes R3, Rial MJ1

1Allergy Department, Severe Asthma Unit, Complexo Hospitalario Universitario A Coruña, A Coruña, Spain
2Pharmacology Department, Complexo Hospitalario Universitario A Coruña, A Coruña, Spain
3Intensive Care Unit, Complexo Hospitalario Universitario A Coruña, A Coruña, Spain

J Investig Allergol Clin Immunol 2024; Vol. 34(6)
doi: 10.18176/jiaci.1007

Key words: Asthma, Tezepelumab, Severe asthma, Monoclonal antibodies, Drug desensitization